Baseline Participant Characteristics in the DIAN‐TU‐001 Trial
The baseline characteristics for DIAN-TU-001 Tau NexGen trial were consistent with clinical features of asymptomatic and symptomatic DIAD. These characteristics were also generally consistent between Cohort 1 and Cohort 2 with the exception of clinical, and cognitive scores.
Authors
- Erica Andreozzi
- Eric McDade (ORCID: https://orcid.org/0000-0002-6764-3866)
- Jorge J. Llibre‐Guerra (ORCID: https://orcid.org/0000-0002-2137-7750)
- Sibabrata Banerjee
- Lon S. S Schneider
- Guoqiao Wang
- Randall J. Bateman
- David B. Clifford
- Larisa Reyderman
- Jin Zhou
Institutions
- University of Southern California (US)
- Washington University in St. Louis (US)
- Keck Hospital of USC (US)
- Eisai (United States) (US)
- Banner Alzheimer’s Institute
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_105299
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00